PTC THERAPEUTICS, INC. financial data

Symbol
PTCT on Nasdaq
Location
Warren, NJ
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 04 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 298% % 42%
Quick Ratio 5% % -7.7%
Debt-to-equity -686% % -130%
Return On Assets 31% %
Operating Margin 44% %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 80,288,305 shares 4.1%
Common Stock, Shares, Outstanding 79,931,766 shares 3.9%
Entity Public Float $1,733,690,074 USD -26%
Common Stock, Value, Issued $79,000 USD 3.9%
Weighted Average Number of Shares Outstanding, Basic 78,471,119 shares 2%
Weighted Average Number of Shares Outstanding, Diluted 87,115,369 shares 13%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $1,779,150,000 USD 98%
Research and Development Expense $446,891,000 USD -16%
Operating Income (Loss) $775,895,000 USD
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $741,003,000 USD 76%
Income Tax Expense (Benefit) $10,720,000 USD -139%
Net Income (Loss) Attributable to Parent $751,723,000 USD
Earnings Per Share, Basic 9 USD/shares
Earnings Per Share, Diluted 8 USD/shares

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $672,617,000 USD 28%
Marketable Securities, Current $1,015,200,000 USD 108%
Inventory, Net $52,688,000 USD 48%
Assets, Current $2,007,803,000 USD 57%
Property, Plant and Equipment, Net $56,970,000 USD -9.8%
Operating Lease, Right-of-Use Asset $80,682,000 USD 36%
Intangible Assets, Net (Excluding Goodwill) $396,466,000 USD 20%
Goodwill $82,341,000 USD 0%
Assets $2,643,700,000 USD 44%
Accounts Payable, Current $36,617,000 USD 175%
Employee-related Liabilities, Current $49,466,000 USD 7%
Contract with Customer, Liability, Current $1,691,000 USD
Liabilities, Current $866,245,000 USD 42%
Deferred Income Tax Liabilities, Net $55,909,000 USD 7.7%
Operating Lease, Liability, Noncurrent $95,488,000 USD 15%
Other Liabilities, Noncurrent $2,579,000 USD 3249%
Liabilities $2,799,458,000 USD -3.4%
Accumulated Other Comprehensive Income (Loss), Net of Tax $5,930,000 USD
Retained Earnings (Accumulated Deficit) $2,829,264,000 USD 21%
Stockholders' Equity Attributable to Parent $155,758,000 USD 85%
Liabilities and Equity $2,643,700,000 USD 44%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $870,103,000 USD 1130%
Net Cash Provided by (Used in) Financing Activities $9,410,000 USD 1643%
Net Cash Provided by (Used in) Investing Activities $184,360,000 USD -60%
Common Stock, Shares Authorized 250,000,000 shares 0%
Common Stock, Shares, Issued 79,931,766 shares 3.9%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $700,546,000 USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $686,300,000 USD 27%
Interest Paid, Excluding Capitalized Interest, Operating Activities $2,156,000 USD -41%
Deferred Tax Assets, Valuation Allowance $857,584,000 USD 2.9%
Deferred Tax Assets, Gross $869,324,000 USD 3.3%
Operating Lease, Liability $107,298,000 USD 11%
Payments to Acquire Property, Plant, and Equipment $1,724,000 USD -82%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $761,996,000 USD
Lessee, Operating Lease, Liability, to be Paid $159,823,000 USD -16%
Property, Plant and Equipment, Gross $94,328,000 USD -32%
Operating Lease, Liability, Current $11,810,000 USD -16%
Lessee, Operating Lease, Liability, to be Paid, Year Two $16,493,000 USD 1.8%
Lessee, Operating Lease, Liability, to be Paid, Year One $18,315,000 USD 13%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure -12%
Deferred Income Tax Expense (Benefit) $2,000 USD
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $52,525,000 USD -43%
Lessee, Operating Lease, Liability, to be Paid, Year Three $11,102,000 USD -21%
Unrecognized Tax Benefits $107,988,000 USD 7840%
Lessee, Operating Lease, Liability, to be Paid, Year Four $7,620,000 USD -58%
Operating Lease, Payments $3,389,000 USD -14%
Additional Paid in Capital $2,667,497,000 USD 5.4%
Amortization of Intangible Assets $18,700,000 USD -86%
Depreciation, Depletion and Amortization $7,221,000 USD -87%
Deferred Tax Assets, Net of Valuation Allowance $11,740,000 USD 57%
Share-based Payment Arrangement, Expense $73,268,000 USD -0.83%